Dr. Braunstein is a board-certified cardiologist and internist, and has been CEO of C2N Diagnostics since its inception. Dr. Braunstein has co-founded and played a senior executive role in numerous emerging life sciences companies. He is a Founder and Managing Director of LifeTech Research (LTR) since 2004. Beside C2N and LTR, he currently serves as a corporate director at Tivorsan Pharmaceuticals, NexGen Medical Systems, and Correx. Dr. Braunstein received his M.D. with highest distinction from Northwestern University Medical School in 1996. Subsequently, he trained in internal medicine at the Brigham and Women’s Hospital, Harvard Medical School until 1999, and as a Fellow in Cardiovascular Medicine and Robert Wood Johnson National Clinical Scholar at the Johns Hopkins Medical Institutions. Additionally, he completed an MBA with management focus in 2004 and maintained an Assistant Professor cardiology faculty position at Johns Hopkins University. He remains an advisor to the Johns Hopkins Carey School of Business and serves on the Commercial Advisory Board for University of Maryland Ventures. In 2010, he was named a Distinguished Alumnus of Johns Hopkins University.
12:00 PM - 12:55 PM (PDT)
Monday, June 8
Brave Innovations: Public and Private Solutions to Advance Alzheimer’s Therapeutics and Diagnostic in a Risk-Averse Climate
Alzheimer’s disease (AD) and AD-related dementias (ADRD) affect more than 5 million Americans and…